Aurora Spine Stock Current Liabilities
| ASAPF Stock | USD 0.29 0.01 3.33% |
Aurora Spine fundamentals help investors to digest information that contributes to Aurora Spine's financial success or failures. It also enables traders to predict the movement of Aurora OTC Stock. The fundamental analysis module provides a way to measure Aurora Spine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aurora Spine otc stock.
Aurora |
Aurora Spine OTC Stock Current Liabilities Analysis
Aurora Spine's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Aurora Spine has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Aurora Fundamentals
| Return On Equity | -0.27 | |||
| Return On Asset | -0.0851 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.10) % | |||
| Current Valuation | 25.13 M | |||
| Shares Outstanding | 66.73 M | |||
| Shares Owned By Insiders | 17.89 % | |||
| Price To Book | 4.22 X | |||
| Price To Sales | 1.70 X | |||
| Revenue | 10.54 M | |||
| Gross Profit | 4.83 M | |||
| EBITDA | (1.9 M) | |||
| Net Income | (2.36 M) | |||
| Cash And Equivalents | 758.98 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 2.27 M | |||
| Debt To Equity | 0.58 % | |||
| Current Ratio | 2.43 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (2.13 M) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 0.53 | |||
| Market Capitalization | 21.68 M | |||
| Total Asset | 10.56 M | |||
| Z Score | 5.4 | |||
| Net Asset | 10.56 M |
About Aurora Spine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aurora Spine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aurora Spine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aurora Spine based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Aurora OTC Stock
Aurora Spine financial ratios help investors to determine whether Aurora OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurora with respect to the benefits of owning Aurora Spine security.